Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.

por König, W, Frickhofen, N, Tesch, H
Publicado 1979

DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias.

por Kochanek, S, Radbruch, A, Tesch, H, Renz, D, Doerfler, W
Publicado 1991

RFLP of the human c-fes proto-oncogene.

por Tesch, H, Olek, K, Geisel, J, Van de Ven, W J, Jücker, M
Publicado 1988

Polymorphism at the FES locus detected by PFGE

por Koch, Klaus, Jücker, M., Michels, M., Van De Ven, W.J.M., Tesch, H.
Publicado 1990

Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.

por Tesch, H., Günther, A., Abts, H., Jücker, M., Klein, S., Krueger, G. R., Diehl, V.
Publicado 1993

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

por Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N.
Publicado 2013

Subcutaneous Trastuzumab for HER2-positive Breast Cancer – Evidence and Practical Experience in 7 German Centers

por Jackisch, C., Müller, V., Dall, P., Neumeister, R., Park-Simon, T.-W., Ruf-Dördelmann, A., Seiler, S., Tesch, H., Ataseven, B.
Publicado en Geburtshilfe Frauenheilkd (2015)

Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428

por Kube, D., Vockerodt, M., Weber, O., Hell, K., Wolf, J., Haier, B., Grässer, F. A., Müller-Lantzsch, N., Kieff, E., Diehl, V., Tesch, H.
Publicado 1999

Classical Hodgkin's disease. Clinical impact of the immunophenotype.

por von Wasielewski, R., Mengel, M., Fischer, R., Hansmann, M. L., Hübner, K., Franklin, J., Tesch, H., Paulus, U., Werner, M., Diehl, V., Georgii, A.
Publicado 1997

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

por Stemmler, H J, diGioia, D, Freier, W, Tessen, H W, Gitsch, G, Jonat, W, Brugger, W, Kettner, E, Abenhardt, W, Tesch, H, Hurtz, H J, Rösel, S, Brudler, O, Heinemann, V
Publicado 2011

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network

por Fasching, P. A., Brucker, S. Y., Fehm, T. N., Overkamp, F., Janni, W., Wallwiener, M., Hadji, P., Belleville, E., Häberle, L., Taran, F.-A., Lüftner, D., Lux, M. P., Ettl, J., Müller, V., Tesch, H., Wallwiener, D., Schneeweiss, A.
Publicado en Geburtshilfe Frauenheilkd (2015)

Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study

por Hein, A., Rack, B., Li, L., Ekici, A. B., Reis, A., Lux, M. P., Cunningham, J. M., Rübner, M., Fridley, B. L., Schneeweiss, A., Tesch, H., Lichtenegger, W., Fehm, T., Heinrich, G., Rezai, M., Beckmann, M W., Janni, W., Weinshilboum, R. M., Wang, L., Fasching, P. A., Häberle, L.
Publicado en Geburtshilfe Frauenheilkd (2017)

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study

por Fasching, P. A., Fehm, T., Kellner, S., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H.-C., Guggenberger, M., Warm, M., Harbeck, N., Würstlein, R., Deuker, J.-U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H.-W., Breitbach, G.-P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesslet, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauß, T., Thomssen, C., Kümmel, S., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Hadji, P., Wallwiener, D., Grischke, E.-M., Beckmann, M. W., Brucker, S. Y.
Publicado en Geburtshilfe Frauenheilkd (2014)